|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2003-2-25
|
|
pubmed:abstractText |
MxA is an antiviral protein exclusively induced by type I interferons (IFN) and some viruses, and MxA gene expression is one of the most appropriate markers for measuring the biologic activity of exogenous IFNbeta.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1526-632X
|
|
pubmed:author |
pubmed-author:BertolottoAA,
pubmed-author:BotteroRR,
pubmed-author:CapobiancoMM,
pubmed-author:Di SapioAA,
pubmed-author:GilloLL,
pubmed-author:GiordanaM TMT,
pubmed-author:LindbergR L PRL,
pubmed-author:MalucchiSS,
pubmed-author:MarnettoFF,
pubmed-author:MelinAA,
pubmed-author:MilanoEE,
pubmed-author:SalaAA
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
25
|
|
pubmed:volume |
60
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
634-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12601105-Antibodies,
pubmed-meshheading:12601105-Biological Availability,
pubmed-meshheading:12601105-GTP-Binding Proteins,
pubmed-meshheading:12601105-Humans,
pubmed-meshheading:12601105-Interferon-beta,
pubmed-meshheading:12601105-Leukocytes, Mononuclear,
pubmed-meshheading:12601105-Multiple Sclerosis,
pubmed-meshheading:12601105-Polymerase Chain Reaction,
pubmed-meshheading:12601105-RNA, Messenger,
pubmed-meshheading:12601105-Reference Values
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Persistent neutralizing antibodies abolish the interferon beta bioavailability in MS patients.
|
|
pubmed:affiliation |
Unità dipartimentale: Centro Riferimento Regionale Sclerosi Multipla (CReSM) and Neurobiologia Clinica, Ospedale Universitario S. Luigi Gonzaga, Orbassano, Torino, Italy. NSGLB@tin.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|
